PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2009.41.1.12200941112Randomized, Multicenter, Phase III Trial of Heptaplatin 1-hour Infusion and 5-Fluorouracil Combination Chemotherapy Comparing with Cisplatin and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric CancerKyung Hee Lee, Myung Soo Hyun, Hoon-Kyo Kim, Hyung Min Jin, Jinmo Yang, Hong Suk Song, Young Rok Do, Hun Mo Ryoo, Joo Seop Chung, Dae Young Zang, Ho-Yeong Lim, Jong Youl Jin, Chang Yeol Yim, Hee Sook Park, Jun Suk Kim, Chang Hak Sohn, Soon Nam Leehttp://www.e-crt.org/upload/pdf/crt-41-12.pdf, http://www.e-crt.org/upload/pdf/crt-41-12.pdf
Cancer Research and Treatment10.4143/crt.2004.36.2.1402004362140Randomized Phase III Trial of Cisplatin, Epirubicin, Leucovorin, 5-Fluorouracil (PELF) Combination versus 5-fluorouracil Alone as Adjuvant Chemotherapy in Curative Resected Stage III Gastric CancerJae Jin Lee, Si-Young Kim, Im sik Shin, Kyung Sam Cho, Hoong-Zae Joo, Choong Yoon, Yoon Wha Kim, Hwi Joong Yoonhttp://www.e-crt.org/upload/pdf/crt-36-140.pdf, http://www.e-crt.org/upload/pdf/crt-36-140.pdf
Cancer Chemotherapy and Pharmacology10.1007/s00280-008-0728-42008632213-218Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancerBiyun Wang, Wen Zhang, Xiaonan Hong, Ye Guo, Jin Lihttps://link.springer.com/content/pdf/10.1007/s00280-008-0728-4.pdf, https://link.springer.com/article/10.1007/s00280-008-0728-4/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-008-0728-4.pdf, https://link.springer.com/content/pdf/10.1007/s00280-008-0728-4.pdf
Lung Cancer10.1016/0169-5002(90)90239-i199063-41425-Fluorouracil infusion and mitomycin combination chemotherapy in the management of patients with advanced non-small-cell lung cancerhttps://api.elsevier.com/content/article/PII:016950029090239I?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029090239I?httpAccept=text/plain
Cancer Chemotherapy and Pharmacology10.1007/s00280-010-1424-8201068137-43Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trialStefano Cascinu, Eva Galizia, Roberto Labianca, Francesco Ferraù, Francesca Pucci, Rosa Rita Silva, Gabriele Luppi, Giordano Domenico Beretta, Rossana Berardi, Mario Scartozzihttp://link.springer.com/content/pdf/10.1007/s00280-010-1424-8.pdf, http://link.springer.com/article/10.1007/s00280-010-1424-8/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-010-1424-8
European Journal of Cancer Supplements10.1016/s1359-6349(03)90086-3200315S2051A Docetaxel (D), cisplatin (C) 5-fluorouracil (F) compared to cisplatin (C) and 5-fluorouracil (F) for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC): Interim results of a randomized phase III trial (V325)E. Van Cutsem, V. Moiseyenko, S. Tjulandin, M. Fodor, C. Boni, E. Zuber, S. Assadourianhttps://api.elsevier.com/content/article/PII:S1359634903900863?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634903900863?httpAccept=text/plain
Cancer10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.0.co;2-a19998551091-1097A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinomaCesar Blajman, L. Balbiani, J. Block, F. Coppola, R. Chacon, L. Fein, S. Bonicatto, A. Alvarez, A. Schmilovich, F. M. Delgadohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1097-0142(19990301)85:5%3C1091::AID-CNCR12%3E3.0.CO;2-A, https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0142(19990301)85:5%3C1091::AID-CNCR12%3E3.0.CO;2-A
Annals of Oncology10.1093/oxfordjournals.annonc.a0578581991210751-754Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A Phase II trialA.J. Lacave, F.J. Barón, L.M. Antón, E. Estrada, L.M.G. De Sande, I. Palacio, E. Esteban, J.M. Gracia, J.M. Buesa, O.A. Fernández, M. González Barónhttps://api.elsevier.com/content/article/PII:S0923753420315696?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753420315696?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/2/10/751/538774/2-10-751.pdf
Lung Cancer10.1016/0169-5002(95)96409-o1995121-2145A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracilhttps://api.elsevier.com/content/article/PII:016950029596409O?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029596409O?httpAccept=text/plain
Cancer Chemotherapy and Pharmacology10.1007/s00280-010-1281-5201067141-48Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trialMatteo Dalla Chiesa, Gianluca Tomasello, Sebastiano Buti, Rodrigo Kraft Rovere, Matteo Brighenti, Silvia Lazzarelli, Gianvito Donati, Rodolfo Passalacquahttp://link.springer.com/content/pdf/10.1007/s00280-010-1281-5.pdf, http://link.springer.com/article/10.1007/s00280-010-1281-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-010-1281-5